Patent application number | Description | Published |
20080312257 | Triazolopyrimidine derivatives as ADP P2Y12 receptor antagonists - The present invention is directed to novel bicyclic triazolopyrimidine compounds of Formula (I) or a form thereof: | 12-18-2008 |
20090176806 | SUBSTITUTED PYRROLINE KINASE INHIBITORS - The present invention is directed to novel substituted pyrroline compounds useful as kinase inhibitors and methods for treating or ameliorating a kinase mediated disorder. | 07-09-2009 |
20090181982 | SUBSTITUTED PYRROLINE KINASE INHIBITORS - The present invention is directed to novel substituted pyrroline compounds useful as kinase inhibitors and methods for treating or ameliorating a kinase mediated disorder. | 07-16-2009 |
20100240650 | SUBSTITUTED PYRROLINES AS KINASE INHIBITORS - The present invention is directed to novel substituted pyrroline compounds useful as kinase or dual-kinase inhibitors, methods for producing such compounds and methods for treating or ameliorating a kinase or dual-kinase mediated disorder. | 09-23-2010 |
20110105490 | 2,3-DIHYDRO-1H-ISOINDOL-1-IMINE DERIVATIVES USEFUL AS THROMBIN PAR-1 RECEPTOR ANTAGONIST - The present invention is directed to novel 2,3-dihydro-1H-isoindol-1-imine derivatives, pharmaceutical compositions containing them and their use in the treatment of disorders and conditions modulated by the thrombin PAR-1 receptor antagonists. | 05-05-2011 |
20120077847 | ALPHA-KETOAMIDE DERIVATIVES USEFUL ENDOTHELIAL LIPASE INHIBITORS - The present invention is directed to α-ketoamide derivatives, pharmaceutical compositions containing them and their use in the treatment of disorders and conditions modulated by endothelial lipase, for example, cardiovascular disorders. | 03-29-2012 |
20130210806 | TRICYCLIC INDOLE DERIVATIVES USEFUL ENDOTHELIAL LIPASE INHIBITORS - The present invention is directed to tricyclic indole derivatives, pharmaceutical compositions containing them and their use in the treatment of disorders and conditions modulated by endothelial lipase, for example, cardiovascular disorders. | 08-15-2013 |
20150119366 | Novel Alkylated Imino Sugars Exhibiting Glucosidase Inhibition and Their Method of Use - Pharmaceutical compositions of the invention comprise alkylated imino sugars derivatives having a disease-modifying action in the treatment of diseases associated with glucosidase activity that include Viral hemorrhagic fevers, and any other diseases involving glucosidase activity. | 04-30-2015 |